Saboor Ejaz Randhawa, MBBS

Saboor Randhawa practices at SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri.

Saboor Randhawa's NPI, 1407379852, was assigned on July 18, 2017. Saboor Randhawa holds Nebraska license TEP8707.

Saboor Randhawa's primary practice is SLUCare Physician Group Dermatology Pathology, at 1225 S Grand Blvd, 3rd Floor, Saint Louis, MO 63104. The practice phone is (314) 617-2709.

Saboor Randhawa's primary practice is SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri. Saboor Randhawa is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Saboor Randhawa to 2 more hospitals, 1 clinical lab and 1 group practice or clinic, each named with a free account. Saboor Randhawa's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Saboor Randhawa practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Saboor Randhawa's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Saboor Randhawa is licensed in Nebraska.

CMS data shows 269 Medicare services from Saboor Randhawa across 6 procedure codes in 2024, for 134 Medicare patients. Medicare paid $26,372 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Saboor Randhawa in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Saboor Randhawa's median patient age at 70, with 50% women.

In 2024, Saboor Randhawa wrote 251 Medicare Part D claims for 62 patients. 78% of them were for generic drugs. CMS names the drug for 132 of them, across 8 drugs with 11 or more claims each, at $94,292 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Saboor Randhawa for performance year 2024, reported as part of a group. Saboor Randhawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Saboor Randhawa from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 64% of the total. Seagen Inc. paid the most, $165.